熱門資訊> 正文
TuHURA合并更新后，Kintara股价上涨10%
2024-10-15 01:48
- Shares of Kintara Therapeutics (NASDAQ:KTRA) climbed 10% Monday after the company announced the record date for contingent value rights, or CVRs, to be issued under its merger agreement with TuHURA Biosciences and the merger’s proposed closing date.
- Kintara (KTRA) said the CVRs are expected to be issued to Kintara (KTRA) stockholders of record as of Oct. 17, but the date is subject to change based on the merger's final closing date, according to a statement.
- The proposed merger is expected to close on Oct. 18, subject to regulatory approval and certain closing conditions.
- The CVRs will be issued immediately prior to a proposed 1-for-35 reverse stock split of Kintara (KTRA) shares and the merger closing.
- Kintara (KTRA) announced plans to merge with TuHURA through an all-stock deal in April. The combined company’s stock is expected to trade on Nasdaq under the symbol HURA.
More on Kintara Therapeutics
- Financial information for Kintara Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
